KAAL

Mayo Clinic is partnering with IBM Watson Health to help physicians match cancer patients to clinical trials. More patients are enrolling in Mayo's breast cancer clinical trials, giving them another chance. "Right now only five percent of patients with cancer participate in clinical trials. The number one reason why patients don't participate in studies is that they're not aware of opportunities," said Tufia Haddad, M.D., a Mayo Clinic oncologist and physician leader for the Watson for Clinical Trial Matching Project.

Reach: KAAL-TV is the ABC affiliate for the Rochester, MN - Mason City, IA, market. The station is owned by Hubbard Broadcasting Inc.

Additional coverage: Healthcare Analytics News, MobiHealthNews, Becker’s Hospital Review, Medical Xpress, Clinical Innovation + Technology, DOTmed.com

Context: Mayo Clinic and IBM Watson Health today unveiled results from early use of the Watson for Clinical Trial Matching, an IBM cognitive computing system. Use of this system in the Mayo Clinic oncology practice has been associated with more patients enrolled in Mayo’s breast cancer clinical trials. The organizations also announced an agreement that aims to extend and expand training and use of the system. Training on trials for additional cancer types is already underway. Currently, the system is trained to support clinical trial matching for breast, lung and gastrointestinal cancers. “Novel solutions are necessary to address this unmet clinical need, advance cancer research and treatments, and, in turn, improve the health outcomes of patients,” says Tufia Haddad, M.D., a Mayo Clinic oncologist and physician leader for the Watson for Clinical Trial Matching project. More information can be found on Mayo Clinic News Network.

Contact: Rhoda Fukushima Madson

Tags: artificial Intelligence, Breast Cancer, clinical trials, Dr. Tufia Haddad, gastrointestinal cancer, IBM, IBM Watson, KAAL, Lung Cancer, Uncategorized